Company profile: Aprea Therapeutics
1.1 - Company Overview
Company description
- Provider of oncology therapeutics focused on discovering and developing anticancer compounds that reactivate the tumor suppressor protein p53, including APR-246, a first-in-class small molecule drug candidate in clinical development.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Aprea Therapeutics
Pierian Biosciences
HQ: United States
Website
- Description: Provider of cancer diagnostics, including ChemoINTEL, a chemosensitivity assay that measures tumor cell apoptotic response to cytotoxic agents to aid chemotherapy selection; ImmunoINTEL, a flow cytometry-based platform that characterizes and quantifies immune and tumor cell populations for immunotherapy selection; and PathwayINTEL, a proteomic profiling assay that identifies oncogenic drivers to help select targeted or biologic therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pierian Biosciences company profile →
Allos Therapeutics
HQ: United States
Website
- Description: Provider of anti-cancer therapeutics, developing and commercializing treatments including FOLOTYN, a folate analogue metabolic inhibitor that accumulates in cancer cells to cause cell death. Also offers Causal AI to predict effects of clinical interventions for complex generics development, and Licensing & Pipeline co-development and drug licensing to make medications more accessible.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allos Therapeutics company profile →
Intact Medical
HQ: United States
Website
- Description: Provider of minimally invasive systems for volumetric excision of tissue for diagnostic and therapeutic applications in select cancer markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intact Medical company profile →
Atara Biotherapeutics
HQ: United States
Website
- Description: Provider of off-the-shelf, allogeneic T-cell immunotherapies, conducting clinical studies to evaluate safety and efficacy; offering expanded access to investigational drugs for treatment use; providing educational grants in T-cell immunotherapy; and supplying healthcare providers with information on products and clinical application.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atara Biotherapeutics company profile →
Medite Cancer Diagnostics
HQ: United States
Website
- Description: Provider of development, manufacture, and distribution as a mid-sized industrial corporation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medite Cancer Diagnostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Aprea Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Aprea Therapeutics
2.2 - Growth funds investing in similar companies to Aprea Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Aprea Therapeutics
4.2 - Public trading comparable groups for Aprea Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →